Dr. Sriharan Sivalingam, MD

Dr. Sivalingam practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Sivalingam's NPI, 1740553015, was assigned on February 17, 2012. Dr. Sivalingam holds Wisconsin license 56820.

Dr. Sivalingam's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Sivalingam's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Sivalingam is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Sivalingam to 3 more hospitals, 2 clinical labs and 1 group practice or clinic, each named with a free account. Dr. Sivalingam's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sivalingam practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sivalingam's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Sivalingam is licensed in Wisconsin.

CMS data shows 392 Medicare services from Dr. Sivalingam across 11 procedure codes in 2024, for 191 Medicare patients. Medicare paid $64,486 for them.

CMS counts 191 Medicare patients who saw Dr. Sivalingam in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sivalingam's median patient age at 68, with 51% women.

In 2024, Dr. Sivalingam wrote 117 Medicare Part D claims for 86 patients. 89% of them were for generic drugs. CMS names the drug for 91 of them, across 3 drugs with 11 or more claims each, at $617 in total drug cost. In 2023, CMS named 71 claims across 4 drugs.

Dr. Sivalingam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sivalingam as offering telehealth.

Dmand AI links Dr. Sivalingam to 2 clinical trials. Conditions studied include Kidney Calculi, Ureteral Calculi and Ureterolithiasis.

CMS Open Payments shows 420 general payments to Dr. Sivalingam from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $131,305.